Rennova Health, Inc. (RNVA) Financial Statements (2025 and earlier)
Company Profile
Balance Sheet (Statement of Financial Position) ($ in thousands)
| 12/31/2023
| 12/31/2022
| 12/31/2021
| 12/31/2020
| 12/31/2019
| 12/31/2018
| 12/31/2017
|
|
ASSETS |
|
Current Assets |
|
Cash, cash equivalents, and short-term investments | | 499 | 725 | 25 | 17 | 7 | |
|
Cash and cash equivalent | | 499 | 725 | 25 | 17 | 7 | |
|
Receivables | | 5,406 | 3,593 | 1,920 | 4,208 | 4,443 | 2,912 |
|
Inventory, net of allowances, customer advances and progress billings | | 243 | 281 | 445 | 614 | 453 | 237 |
|
Inventory | | 243 | 281 | 445 | 614 | 453 | 237 |
|
Disposal group, including discontinued operation | | | | 185 | 505 | | |
|
Asset, held-for-sale, not part of disposal group | | | | | | 140 | 227 |
|
Other undisclosed current assets | | 215 | 122 | 149 | 0 | 79 | 10 |
|
Total current assets: | | 6,363 | 4,720 | 2,724 | 5,345 | 5,122 | 3,386 |
|
Noncurrent Assets |
|
Operating lease, right-of-use asset | | 574 | 821 | 1,000 | 275 | ✕ | ✕ |
|
Property, plant and equipment | | 4,194 | 4,630 | 7,814 | 8,232 | 8,527 | 2,695 |
|
Long-term investments and receivables | | 9,016 | 9,016 | | | | |
|
Long-term investments | | 9,016 | 9,016 | | | | |
|
Intangible assets, net (including goodwill) | | 259 | 259 | 259 | 509 | 259 | |
|
Intangible assets, net (excluding goodwill) | | 259 | 259 | 259 | 509 | 259 | |
|
Deposits noncurrent assets | | 166 | 188 | 264 | | | |
|
Disposal group, including discontinued operation, noncurrent assets | | | | 201 | 9 | 12 | 29 |
|
Other undisclosed noncurrent assets | | | | | 337 | 279 | 181 |
|
Total noncurrent assets: | | 14,210 | 14,915 | 9,539 | 9,363 | 9,077 | 2,905 |
|
TOTAL ASSETS: | | 20,573 | 19,635 | 12,262 | 14,708 | 14,199 | 6,291 |
|
LIABILITIES AND EQUITY |
|
Liabilities |
|
Current Liabilities |
|
Accounts payable and accrued liabilities | | 31,078 | 28,973 | 34,826 | 29,649 | 20,268 | 11,128 |
|
Taxes payable | ✕ | ✕ | 1,337 | 1,439 | 1,374 | 1,401 | 1,972 |
|
Accounts payable | | 11,514 | 12,135 | 14,252 | 13,691 | 8,156 | 4,189 |
|
Accrued liabilities | | 19,564 | 15,500 | 19,136 | 14,584 | 10,711 | 4,967 |
|
Debt | | 8,843 | 8,443 | 13,025 | 29,874 | 12,776 | 1,616 |
|
Derivative instruments and hedges, liabilities | | 455 | 455 | 455 | 455 | 350 | |
|
Disposal group, including discontinued operation | | 1,456 | 1,449 | 3,814 | 2,793 | 2,298 | 1,973 |
|
Due to related parties | ✕ | | 2,427 | 2,397 | 15,759 | 1,200 | 1,329 |
|
Other undisclosed current liabilities | | 7,476 | 4,615 | 4,660 | 4,888 | 7,524 | 8,837 |
|
Total current liabilities: | | 49,308 | 46,362 | 59,178 | 83,418 | 44,416 | 24,882 |
|
Noncurrent Liabilities |
|
Long-term debt and lease obligation | | | 574 | 2,024 | 159 | | 3,752 |
|
Long-term debt, excluding current maturities | | | | 1,196 | | | 3,752 |
|
Liabilities, other than long-term debt | | 359 | | 78 | | | 12,435 |
|
Accounts payable and accrued liabilities | | | | | | | |
|
Disposal group, including discontinued operation, liabilities | | | | 78 | | | |
|
Operating lease, liability | | 359 | 574 | 827 | 159 | ✕ | ✕ |
|
Derivative instruments and hedges, liabilities | | | | | | | 12,435 |
|
Other undisclosed noncurrent liabilities | | | (574) | | | 32 | |
|
Total noncurrent liabilities: | | 359 | 574 | 2,102 | 159 | 32 | 16,187 |
|
Total liabilities: | | 49,667 | 46,936 | 61,280 | 83,577 | 44,448 | 41,069 |
|
Temporary equity, including noncontrolling interest | | | | | | | 5,835 |
|
Equity |
|
Equity, attributable to parent, including: | | (29,095) | (27,302) | (49,018) | (76,520) | (39,168) | (40,613) |
|
Common stock | | 2,908 | 0 | 4 | 965 | 13 | 198 |
|
Additional paid in capital | | 1,671,572 | 1,342,086 | 819,494 | 509,437 | 375,846 | 128,352 |
|
Accumulated deficit | | (1,703,578) | (1,369,408) | (868,537) | (586,942) | (415,047) | (169,180) |
|
Other undisclosed equity, attributable to parent | | 3 | 20 | 21 | 20 | 20 | 18 |
|
Equity, attributable to noncontrolling interest | | | | | | | |
|
Other undisclosed equity | | | | | 7,650 | 8,919 | |
|
Total equity: | | (29,095) | (27,302) | (49,018) | (68,869) | (30,248) | (40,613) |
|
TOTAL LIABILITIES AND EQUITY: | | 20,573 | 19,635 | 12,262 | 14,708 | 14,199 | 6,291 |
Income Statement (P&L) ($ in thousands)
Comprehensive Income ($ in thousands)
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission
(SEC)
through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from
the 10-K and 10-Q reports submitted
to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP
Taxonomy.
Please review the original filings
for a more detailed information.